This study is the first to assess the diagnostic value of [68Ga]Ga‐DOTA‐Siglec‐9 PET/CT in multiple patients with relapsing GCA and to explore the roles of Siglec‐9 and VAP‐1 in GCA pathogenesis (Fig. S1). This evidence concerns the gene SIGLEC9 and temporal arteritis.